• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting 30-day mortality of aortic valve replacement by the AVR score.AVR 评分预测主动脉瓣置换术 30 天死亡率。
Neth Heart J. 2011 Jun;19(6):273-8. doi: 10.1007/s12471-011-0103-7.
2
Aortic valve replacement after previous coronary artery bypass grafting.既往冠状动脉旁路移植术后的主动脉瓣置换术。
Ann Thorac Surg. 1996 Nov;62(5):1424-30. doi: 10.1016/0003-4975(96)00635-2.
3
Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome?老年患者在进行主动脉瓣置换术的同时加做冠状动脉旁路移植术会影响其早期和长期预后吗?
Heart Vessels. 2020 Apr;35(4):487-501. doi: 10.1007/s00380-019-01519-6. Epub 2019 Oct 18.
4
Early results of aortic valve replacement with or without concomitant coronary artery bypass grafting.主动脉瓣置换术联合或不联合同期冠状动脉旁路移植术的早期结果。
Scand J Thorac Cardiovasc Surg. 1991;25(1):29-35. doi: 10.3109/14017439109098080.
5
Moderate aortic stenosis in coronary artery bypass grafting patients more than 70 years of age: to replace or not to replace?70 岁以上冠状动脉旁路移植术患者的中度主动脉瓣狭窄:换瓣还是不换瓣?
Ann Thorac Surg. 2010 Nov;90(5):1495-9; discussion 1499-500. doi: 10.1016/j.athoracsur.2010.06.036.
6
Aortic Valve Replacement With or Without Concurrent Coronary Artery Bypass Grafting in Octogenarians: Eight-Year Cohort Study.老年患者行主动脉瓣置换术加或不加同期冠状动脉旁路移植术:八年队列研究
Heart Lung Circ. 2017 Jan;26(1):82-87. doi: 10.1016/j.hlc.2016.04.028. Epub 2016 Jul 6.
7
Previous coronary artery bypass grafting is not a risk factor for aortic valve replacement.既往冠状动脉旁路移植术并非主动脉瓣置换术的危险因素。
Ann Thorac Surg. 1997 Sep;64(3):651-7; discussion 657-8. doi: 10.1016/s0003-4975(97)00622-x.
8
Management of mild aortic stenosis at the time of coronary artery bypass surgery: should the valve be replaced?冠状动脉搭桥手术时轻度主动脉瓣狭窄的处理:瓣膜是否应置换?
Ann Thorac Surg. 2009 Oct;88(4):1224-31. doi: 10.1016/j.athoracsur.2009.05.085.
9
Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement?体重指数:主动脉瓣置换术患者30天或6个月死亡率的危险因素?
J Heart Valve Dis. 2006 May;15(3):336-44.
10
Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery?行主动脉瓣置换和冠状动脉旁路移植术时增加 Cox 迷宫 III 手术是否会增加手术风险?
J Thorac Cardiovasc Surg. 2012 Apr;143(4):936-44. doi: 10.1016/j.jtcvs.2011.12.018. Epub 2012 Jan 13.

引用本文的文献

1
What Can We Learn from the Past by Means of Very Long-Term Follow-Up after Aortic Valve Replacement?通过主动脉瓣置换术后的超长期随访,我们能从过去学到什么?
J Clin Med. 2021 Aug 31;10(17):3925. doi: 10.3390/jcm10173925.
2
The impact of nutritional status and appetite on the hospital length of stay and postoperative complications in elderly patients with severe aortic stenosis before aortic valve replacement.营养状况和食欲对老年重度主动脉瓣狭窄患者主动脉瓣置换术前住院时间及术后并发症的影响。
Kardiochir Torakochirurgia Pol. 2016 Jun;13(2):105-12. doi: 10.5114/kitp.2016.61042. Epub 2016 Jun 30.

本文引用的文献

1
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.胸外科医师协会2008年心脏手术风险模型:第1部分——冠状动脉搭桥手术
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053.
2
Minimal access aortic valve replacement using a minimal extracorporeal circulatory system.使用最小体外循环系统的微创主动脉瓣置换术。
Ann Thorac Surg. 2009 Mar;87(3):720-5. doi: 10.1016/j.athoracsur.2008.12.016.
3
Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue.再次心脏手术期间的不良事件:发生率、特征及救治
J Thorac Cardiovasc Surg. 2008 Feb;135(2):316-23, 323.e1-6. doi: 10.1016/j.jtcvs.2007.08.060.
4
Predictors of mortality after aortic valve replacement.主动脉瓣置换术后死亡率的预测因素。
Eur J Cardiothorac Surg. 2007 Sep;32(3):469-74. doi: 10.1016/j.ejcts.2007.06.012. Epub 2007 Jul 19.
5
Cardiac procedures in patients with a body mass index exceeding 45: outcomes and long-term results.体重指数超过45的患者的心脏手术:结果与长期随访
Ann Thorac Surg. 2007 Jul;84(1):3-9; discussion 9. doi: 10.1016/j.athoracsur.2007.03.024.
6
Cardiac surgery in patients with body mass index of 50 or greater.体重指数为50或更高的患者的心脏手术。
Ann Thorac Surg. 2007 Apr;83(4):1403-11. doi: 10.1016/j.athoracsur.2006.10.076.
7
Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement?体重指数:主动脉瓣置换术患者30天或6个月死亡率的危险因素?
J Heart Valve Dis. 2006 May;15(3):336-44.
8
Determinants of operative mortality in valvular heart surgery.心脏瓣膜手术中手术死亡率的决定因素。
J Thorac Cardiovasc Surg. 2006 Mar;131(3):547-57. doi: 10.1016/j.jtcvs.2005.10.041.
9
Current determinants of operative mortality in 1400 patients requiring aortic valve replacement.1400例需要进行主动脉瓣置换术患者手术死亡率的当前决定因素。
Ann Thorac Surg. 2003 Jul;76(1):75-83. doi: 10.1016/s0003-4975(03)00341-2.
10
Impact of body mass index and albumin on morbidity and mortality after cardiac surgery.体重指数和白蛋白对心脏手术后发病率和死亡率的影响。
J Thorac Cardiovasc Surg. 1999 Nov;118(5):866-73. doi: 10.1016/s0022-5223(99)70056-5.

AVR 评分预测主动脉瓣置换术 30 天死亡率。

Predicting 30-day mortality of aortic valve replacement by the AVR score.

机构信息

Department of Cardiology, St. Antonius Hospital, P.O. Box 2500, 3435 CM, Nieuwegein, the Netherlands,

出版信息

Neth Heart J. 2011 Jun;19(6):273-8. doi: 10.1007/s12471-011-0103-7.

DOI:10.1007/s12471-011-0103-7
PMID:21494889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3111570/
Abstract

OBJECTIVES

The objective of this study is to develop a simple risk score to predict 30-day mortality of aortic valve replacement (AVR).

METHODS

In a development set of 673 consecutive patients who underwent AVR between 1990 and 1993, four independent predictors for 30-day mortality were identified: body mass index (BMI) ≥30, BMI <20, previous coronary artery bypass grafting (CABG) and recent myocardial infarction. Based on these predictors, a 30-day mortality risk score-the AVR score-was developed. The AVR score was validated on a validation set of 673 consecutive patients who underwent AVR almost two decennia later in the same hospital.

RESULTS

Thirty-day mortality in the development set was ≤2% in the absence of any predictor (class I, low risk), 2-5% in the solitary presence of BMI ≥30 (class II, mild risk), 5-15% in the solitary presence of previous CABG or recent myocardial infarction (class III, moderate risk), and >15% in the solitary presence of BMI <20, or any combination of BMI ≥30, previous CABG or recent myocardial infarction (class IV, high risk). The AVR score correctly predicted 30-day mortality in the validation set: observed 30-day mortality in the validation set was 2.3% in 487 class I patients, 4.4% in 137 class II patients, 13.3% in 30 class III patients and 15.8% in 19 class IV patients.

CONCLUSIONS

The AVR score is a simple risk score validated to predict 30-day mortality of AVR.

摘要

目的

本研究旨在开发一种简单的风险评分,以预测主动脉瓣置换术(AVR)的 30 天死亡率。

方法

在 1990 年至 1993 年间连续接受 AVR 的 673 例患者的发展数据集,确定了四个独立的 30 天死亡率预测因子:体重指数(BMI)≥30、BMI<20、既往冠状动脉旁路移植术(CABG)和近期心肌梗死。基于这些预测因素,开发了 30 天死亡率风险评分-AVR 评分。该 AVR 评分在同一医院近二十年后对 673 例连续接受 AVR 的验证数据集进行了验证。

结果

在无任何预测因子的情况下,发展数据集的 30 天死亡率为≤2%(I 级,低风险),单独存在 BMI≥30 时为 2-5%(II 级,轻度风险),单独存在既往 CABG 或近期心肌梗死时为 5-15%(III 级,中度风险),且 BMI<20 时或任何 BMI≥30、既往 CABG 或近期心肌梗死的组合存在时>15%(IV 级,高风险)。AVR 评分正确预测了验证数据集的 30 天死亡率:验证数据集的观察到的 30 天死亡率在 487 例 I 级患者中为 2.3%,在 137 例 II 级患者中为 4.4%,在 30 例 III 级患者中为 13.3%,在 19 例 IV 级患者中为 15.8%。

结论

AVR 评分是一种简单的风险评分,经验证可预测 AVR 的 30 天死亡率。